Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) recently saw a big drop in its stock price due to disappointing first-quarter ...

Explore Regeneron's Q1 2025 earnings with updates on Dupixent growth, EYLEA challenges, FDA hurdles, and upcoming approvals.

First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 bil ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Days after the terrorist attack in Jammu and Kashmir's Pahalgam, the website of the Army College of Nursing has been hacked, allegedly by a Pakistan-based hacker group called Team Insane PK.

Following the Pahalgam terror attack, which claimed 26 lives, the Pakistan Stock Exchange website went offline. India retaliated with diplomatic downgrades ...

Sanofi-Regeneron’s Dupixent received the FDA’s nod for a skin condition. The FDA sent Regeneron a complete response letter, rejecting its bid to stretch the administration of high-dose Eylea from a ...

The Pentagon quietly scrubbed an advisory board’s website after a fired aide to Defense Secretary Pete Hegseth complained that it was stocked with holdovers hostile to President Donald Trump who ...

THIS DINNER BY LEADERS AT THAT NOW DEFUNCT SCHOOL IN GENTILLY MADE PUBLIC WITH TENS OF THOUSANDS OF OTHER STATE EDUCATION RECORDS, ALL POSTED ON A NEWLY LAUNCHED WEBSITE BY LOUISIANA TREASURER ...